Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Nephroprotection in Cardiac Surgery
NCT03527381Phase 2Completed
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
01
Overview
Phase 2, randomised trial of nitric oxide in acute kidney injury (AKI) (2 arms). Primary endpoint: Acute kidney injury rate at 48 hours. Started Sep 2015; status: completed.
02
Drugs
nitric oxide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03527381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527381.